Abstract
Background
The management of T1 colorectal cancer after local resection is controversial. Regional lymph node metastasis often occurs, requiring subsequent colonic resection. The aim of this study was to reevaluate the risk factors of nodal metastasis of T1 colorectal cancer, especially to examine lymphatic vessel invasion in serially prepared hematoxylin and eosin sections and D2-40 immunostained sections to determine which is a better indicator of lymph node metastasis of T1 colorectal cancer.
Methods
The study investigated 120 patients who underwent bowel resection and were histologically diagnosed to have T1 colorectal cancer in Kanagawa Cancer Center Hospital from 1995 to 2005. Serially prepared paraffin sections were stained with hematoxylin and eosin, or immunostained with D2-40 antibody or von Willebrand factor, and reevaluated for lymphatic vessel invasion and other risk factors, including venous invasion, histological grade, depth of submucosal invasion, and budding.
Results
Lymphatic invasion diagnosed with either hematoxylin and eosin staining (p = 0.022), or D2-40 immunostaining (p = 0.001), and budding (p = 0.013) were significant risk factors for lymph node metastasis in the univariate analysis. Venous involvement, histological grade, or depth of submucosal invasion was not significant. The multivariate logistic regression analysis for the three risk factors found lymphatic invasion diagnosed with D2-40 as an independent risk factor (odds ratio 6.048, p = 0.018, CI 1.360–26.89). The sensitivity, specificity, positive predictive value, and negative predictive value were 58 %, 88 %, 35 %, and 95 %, respectively.
Conclusions
Lymphatic vessel invasion diagnosed with D2-40 was a better indicator to evaluate the risk for lymph node metastasis by T1 colorectal cancer.
Similar content being viewed by others
References
Okabe S, Shia J, Nash G et al (2004) Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 8:1032–1039
Tanaka S, Haruma K, Teixeira CR et al (1995) Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 91:419–427
Ishii M, Ota M, Saito S et al (2009) Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int J Colorectal Dis 24:1069–1074
Ueno H, Motizuki H, Hashiguchi Y et al (2004) Risk factor for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385–394
Wang HS, Liang WY, Lin TC et al (2005) Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 48:1182–1192
Morodomi T, Isomoto H, Shirouzu K et al (1989) An index for estimating the probability of lymph node metastasis in rectal cancers: lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer (Phila) 63:539–543
Volk EE, Goldbulm JR, Petras RE et al (1995) Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 109:1801–1807
Kitajima K, Fujimori T, Fujii S et al (2004) Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 39:534–543
Sakuragi M, Togashi K, Konishi F et al (2003) Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum 46:1626–1632
Nascimbeni R, Burgart LJ, Nivatvongs S et al (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206
Hackelsberger A, Fruehmogen P, Weiler H et al (1995) Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma. Endoscopy 27:153–158
Muller S, Chesner IM, Egan MJ et al (1989) Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut 30:1385–1391
Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumor. Lab Invest 82:1255–1257
Netzer P, Forster C, Biral R et al (1998) Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut 43:669–674
Coverlizza S, Risio M, Ferrari A et al (1989) Colorectal adenomas containing invasive carcinoma: pathologic assessment of lymph node metastasis potential. Cancer (Phila) 64:1937–1947
Cranley JP, Petras RE, Carey WD et al (1986) When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 91:419–427
Netzer P, Binek J, Hammer B et al (1997) Significance of histologic criteria for the management of patients with malignant colorectal polyps and polypectomy. Scand J Gastroenterol 32:910–916
Cooper HS, Deppisch LM, Gourley WK et al (1995) Endoscopically removed malignant colorectal polyps: clinicopathologic correlation. Gastroenterology 108:1657–1665
Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcoma. Mod Pathol 15:434–440
Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) UICC International Union Against Cancer: TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, New York
Walgenbach-Bruenagel G, Tolba RH, Varnai AD et al (2006) Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res 38:438–444
Saad RS, Kordunsky L, Liu YL et al (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19:1317–1323
Ueno H, Murphy J, Jass JR et al (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology (Oxf) 40:127–132
Okuyama T, Nakamura T, Yamaguchi M (2003) Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum 46:1400–1406
Fogt F, Zimmerman RL, Ross HM et al (2004) Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 11:47–50
Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y- antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82–90
Eehard H, Rietveld FJR, Brocker EB et al (1996) Phenotype of normal cutaneous microvasculature. J Invest Dermatol 106:135–140
Mescoli C, Albertoni L, Pucciarelli S et al (2012) Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 30:965–971
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Wada, H., Shiozawa, M., Sugano, N. et al. Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer. Int J Clin Oncol 18, 1025–1031 (2013). https://doi.org/10.1007/s10147-012-0490-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-012-0490-9